Copy and past this URL to read the full article about this new drug test:
http://www.technologyreview.com/biomedicine/26284/?p1=A2&a=f#afteradbody
This is one that I would ask my daughter's doctor to look into. Here is just an the beginning of the article:
A Drug Shows Promise in Autism
A chemical that alters chemical signaling seems to ease anxiety and other symptoms.
By Karen Weintraub
WEDNESDAY, SEPTEMBER 15, 2010
Though the research is still preliminary, scientists appear to be closing in on a molecular explanation for at least some cases of autism. Research in lab animals, cadavers, and now in a small clinical trial in children seems to support the idea that autism is caused by a lack of chemical regulation in synapses, the junction between brain cells.
Alleviating autism: A drug called arbaclofen (its chemical structure is shown above) appears to ease anxiety and some other symptoms in a small study of children with autism.
Credit: Seaside Therapeutics
The latest evidence for this comes from a clinical trial of 25 autistic children ages six to 17. The trial was conducted by Seaside Therapeutics of Cambridge, Massachusetts. In unpublished data released last week, the company says the children seemed to respond well to the drug arbaclofen and suffer minimal side effects. Arbaclofen is related to the drug baclofen, a commonly used muscle relaxer and antispastic agent. The children took the drug for eight weeks, and most saw significant improvements in measures of irritability and communication, two common problems in autism.
The finding is considered preliminary because the study was not placebo-controlled, meaning scientists couldn't compare children taking the drug to those taking a placebo. This is especially important in studies of autism because many of the tests used to assess patients are subjective, including behavioral evaluations from parents and clinicians, says Jeremy Veenstra-VanderWeele, assistant professor of psychiatry, pediatrics, and pharmacology at Vanderbilt University. About a half-dozen of his patients were involved in the trial.
No comments:
Post a Comment